Literature DB >> 22031245

Pregnancy-associated breast cancer.

Srividya Viswanathan1, Bhuvaneswari Ramaswamy.   

Abstract

As women delay childbirth, the incidence of pregnancy-associated breast cancer is expected to increase. A high degree of suspicion is necessary to ensure timely investigation and diagnosis of breast cancer in a pregnant woman with a suspicious breast lump. Surgery as an initial approach is more suitable when diagnosis is made in the first trimester and systemic therapy can be delayed to second trimester. Diagnosis of breast cancer in the later stages of pregnancy can be managed with primary chemotherapy or surgery. A multidisciplinary approach involving medical and surgical oncologists, high-risk obstetric care, genetic counselors, pharmacists, radiation oncologists, and neonatologist is highly recommended for the successful management of cancer and pregnancy.

Entities:  

Mesh:

Year:  2011        PMID: 22031245     DOI: 10.1097/GRF.0b013e318236e436

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  3 in total

1.  Challenges in managing breast cancer during pregnancy.

Authors:  Flora Zagouri; Theodora Psaltopoulou; Constantine Dimitrakakis; Rupert Bartsch; Meletios-Athanassios Dimopoulos
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study.

Authors:  Constantine Dimitrakakis; Flora Zagouri; Alexandra Tsigginou; Spyros Marinopoulos; Theodoros N Sergentanis; Antonis Keramopoulos; George C Zografos; Konstantina Ampela; Dimosthenis Mpaltas; Christos Papadimitriou; Meletios-Athanassios Dimopoulos; Aris Antsaklis
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

3.  Pregnancy-associated breast cancer: clinicopathological characteristics of 20 cases with a focus on identifiable causes of diagnostic delay.

Authors:  Derman Basaran; Mert Turgal; Kemal Beksac; Ozgur Ozyuncu; Omer Aran; M Sinan Beksac
Journal:  Breast Care (Basel)       Date:  2014-10       Impact factor: 2.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.